Could NOTIS GLOBAL INCORPORATED (OTCMKTS:NGBL) Change Direction After More Shorts?

July 18, 2017 - By Adrian Mccoy

The stock of NOTIS GLOBAL INCORPORATED (OTCMKTS:NGBL) registered an increase of 7.42% in short interest. NGBL’s total short interest was 842,500 shares in July as published by FINRA. Its up 7.42% from 784,300 shares, reported previously.

The stock increased 100.00% or $0.0001 on July 17, reaching $0.0002. About 353.54M shares traded or 2006.91% up from the average. Notis Global Inc (OTCMKTS:NGBL) has 0.00% since July 18, 2016 and is . It has underperformed by 16.70% the S&P500.

Notis Global, Inc., formerly Medbox, Inc., is a well-known provider of specialized services to the hemp and marijuana industry. The company has market cap of $1.44 million. The Company’s business activities include pursuing license rights in various states where marijuana is legalized in a certain capacity and contracting with independent third parties to cultivate and dispense marijuana and hemp products, where legal, through independent operator agreements and joint ventures; consulting with its clients operating in the hemp and marijuana industry in organization, licensing, development, build-out, maintenance, commencement of activities and through to maturity; distribution of hemp products processed by its contract partners, and ownership, development and management of real estate used by its partners as cultivation centers and dispensaries. It currently has negative earnings.

More important recent Notis Global Inc (OTCMKTS:NGBL) news were published by: which released: “Former Billionaire Cannabis Entrepreneur Settles Securities Fraud Charges for $12M” on March 11, 2017, also published article titled: “Notis Global Expands Hemp And CBD Oil Farm Operations In Pueblo, Colorado”, published: “Notis Global Announces Progress in Farming Operations” on May 04, 2016. More interesting news about Notis Global Inc (OTCMKTS:NGBL) was released by: and their article: “Busting Medbox” with publication date: February 18, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.